These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30943827)

  • 1. Long-Term Outcomes Following Heart Team Revascularization Recommendations in Complex Coronary Artery Disease.
    Patterson T; McConkey HZR; Ahmed-Jushuf F; Moschonas K; Nguyen H; Karamasis GV; Perera D; Clapp BR; Roxburgh J; Blauth C; Young CP; Redwood SR; Pavlidis AN
    J Am Heart Assoc; 2019 Apr; 8(8):e011279. PubMed ID: 30943827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary Heart Team Approach for Complex Coronary Artery Disease: Single Center Clinical Presentation.
    Young MN; Kolte D; Cadigan ME; Laikhter E; Sinclair K; Pomerantsev E; Fifer MA; Sundt TM; Yeh RW; Jaffer FA
    J Am Heart Assoc; 2020 Apr; 9(8):e014738. PubMed ID: 32308096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI.
    Bonzel T; Schächinger V; Dörge H
    Clin Res Cardiol; 2016 May; 105(5):388-400. PubMed ID: 26508415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up.
    Iqbal J; Zhang YJ; Holmes DR; Morice MC; Mack MJ; Kappetein AP; Feldman T; Stahle E; Escaned J; Banning AP; Gunn JP; Colombo A; Steyerberg EW; Mohr FW; Serruys PW
    Circulation; 2015 Apr; 131(14):1269-77. PubMed ID: 25847979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.
    Campos CM; Stanetic BM; Farooq V; Walsh S; Ishibashi Y; Onuma Y; Garcia-Garcia HM; Escaned J; Banning A; Serruys PW;
    Catheter Cardiovasc Interv; 2015 Nov; 86(6):E229-38. PubMed ID: 25946686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of a Dedicated Chronic Total Occlusion PCI Program on Heart Team Decision Making.
    Kaier TE; Hurrell H; Patterson T; Li Kam Wa M; Fisk G; Stewart J; Baig K; Ghosh-Dastidar M; Young CP; Redwood SR; De Silva K; Clapp B; Perera D; Pavlidis AN
    J Invasive Cardiol; 2022 Sep; 34(9):E660-E664. PubMed ID: 35916923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.
    Mancini GB; Farkouh ME; Brooks MM; Chaitman BR; Boden WE; Vlachos H; Hartigan PM; Siami FS; Sidhu MS; Bittner V; Frye R; Fuster V
    J Am Coll Cardiol; 2016 Sep; 68(10):985-95. PubMed ID: 27585501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
    Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR
    Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
    Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
    Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
    Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of Heart Team discussion on decision making for coronary revascularization in patients with complex coronary artery disease.
    Kezerle L; Yohanan E; Cohen A; Merkin M; Ishay Y; Weinstein JM; Cafri C
    J Card Surg; 2020 Oct; 35(10):2719-2724. PubMed ID: 32743834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease.
    Yates MT; Soppa GK; Valencia O; Jones S; Firoozi S; Jahangiri M
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):606-10. PubMed ID: 23402690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.
    Lee PH; Lee JY; Lee CW; Kim SO; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
    Circ Cardiovasc Interv; 2018 Jan; 11(1):e005374. PubMed ID: 29311287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
    Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW;
    Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial.
    Diamond J; Madhavan MV; Sabik JF; Serruys PW; Kappetein AP; Leon MB; Taggart DP; Berland J; Morice MC; Gersh BJ; Kandzari DE; Dressler O; Stone GW
    JACC Cardiovasc Interv; 2018 Dec; 11(24):2441-2450. PubMed ID: 30573053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of bypass versus percutaneous intervention for left main disease.
    Slim M; Meddeb MA; Neffati E; Ghardallou H; Lagren A; Tarmiz A; Kortas C; Gribaa R; Boughzela E
    Tunis Med; 2019 Apr; 97(4):533-540. PubMed ID: 31729703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease.
    Modolo R; Chichareon P; Kogame N; Dressler O; Crowley A; Ben-Yehuda O; Puskas J; Banning A; Taggart DP; Kappetein AP; Sabik JA; Onuma Y; Stone GW; Serruys PW
    J Am Coll Cardiol; 2019 Apr; 73(15):1877-1886. PubMed ID: 30999989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.